Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to Buy Personalis - MedCity News

A health tech company is acquiring a genomics lab and expanding AI-powered cancer testing. This could make personalized cancer diagnosis available to more patients and improve early detection.